Reseligo

Medicinal product

(Invented) name

Reseligo

Active substance (s)

Goserelinas

Strength

3,6 mg

Pharmaceutical form

implantas užpildytame švirkšte

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02AE03, Goserelin

Marketing authorisation holder

Zentiva k.s., Čekija

Date of authorisation

2015-11-18

Date of renewal

2023-01-20

Documents

3840_Reseligo_perr2023-01-20.docx

3840_pakuotes lapelis_2023-01-20.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

CZ/H/1434/001

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Viename implante yra	1 vnt.
Goserelinas	3,6 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
59176	73399	1073399	užpildytas švirkštas	N1		Receptinis	LT/1/15/3840/001	Tiekiama	-	-	No	-	-
64255	78715	1078715	užpildytas švirkštas	N2		Receptinis	LT/1/15/3840/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-01-20	Perregistruotas
2015-11-18	Registruotas